Breaking News Instant updates and real-time market news.

CISN

Cision

$11.38

-0.4 (-3.40%)

, LNG

Cheniere Energy

$59.82

-0.33 (-0.55%)

10:16
01/03/19
01/03
10:16
01/03/19
10:16

Fly Intel: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Cision (CISN) initiated with a Neutral at Goldman Sachs. 2. Cheniere Energy (LNG) initiated with a Buy at UBS. 3. OptimizeRx (OPRX) initiated with an Outperform at William Blair. 4. Comerica (CMA) initiated with a Buy at Argus. 5. Kirkland Lake Gold (KL) initiated with a Buy at Roth Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

CISN

Cision

$11.38

-0.4 (-3.40%)

LNG

Cheniere Energy

$59.82

-0.33 (-0.55%)

OPRX

OptimizeRx

$12.51

0.5 (4.16%)

CMA

Comerica

$69.65

-0.08 (-0.11%)

KL

Kirkland Lake Gold

$26.48

0.4 (1.53%)

  • 16

    Jan

CISN Cision
$11.38

-0.4 (-3.40%)

01/03/19
GSCO
01/03/19
INITIATION
Target $12
GSCO
Neutral
Cision initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst George Tong started Cision with a Neutral rating and $12 price target. The analyst believes Cision has an "attractive market leadership position" in the public relations software and services industry but thinks near-term upside could be limited by transaction revenue headwinds. He views the stock's current valuation as fair.
10/08/18
DBAB
10/08/18
DOWNGRADE
DBAB
Hold
Cision downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank transferred coverage of Cision to Michael Turrin who set a Hold rating and $18 price target on shares. Deutsche Bank previously had an Buy rating on the name.
08/15/18
08/15/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Cision (CISN) initiated with an Outperform at William Blair. 2. ObsEva (OBSV) resumed with an Outperform at Leerink. 3. Idera Pharmaceuticals (IDRA) resumed with an Overweight at JPMorgan. 4. DTE Energy (DTE) initiated with an Equal Weight at Barclays. 5. Tellurian (TELL) initiated with an Outperform at Baird. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/15/18
WBLR
08/15/18
INITIATION
WBLR
Outperform
Cision initiated with an Outperform at William Blair
William Blair analyst Timonthy McHugh initiated Cision with an Outperform rating, telling investors in a research note that while there are "solid" competitors, he believes that Cision's scale, brand, data, breadth of solutions and technology offer a competitive advantage. Cision's technology platform quality and breadth of services have been significantly enhanced during the last few years through internal technology investments and an aggressive pace of acquisitions, he says, contending that though the company's pricing power and renewal rates are "admittedly lower than we would have guessed," he views Cision as a leading provider of technology and data that is critical for communications professionals to operate on a day-to-day basis.
LNG Cheniere Energy
$59.82

-0.33 (-0.55%)

01/03/19
UBSW
01/03/19
INITIATION
Target $72
UBSW
Buy
Cheniere Energy initiated with a Buy at UBS
UBS analyst Shneur Gershuni started Cheniere Energy with a Buy rating and $72 price target. The analyst believes the company is well positioned for long term growth.
12/03/18
GUGG
12/03/18
INITIATION
Target $85
GUGG
Buy
Cheniere Energy assumed with a Buy at Guggenheim
Guggenheim analyst Michael LaMotte assumed coverage of Cheniere Energy from analyst Matthew Phillips with a Buy rating and $85 price target. The rating is unchanged and the target is raised from $80 relative to Phillips' prior coverage.
01/02/19
GSCO
01/02/19
NO CHANGE
Target $24
GSCO
Conviction Buy
Kinder Morgan remains top pick among midstream energy stocks, says Goldman Sachs
Goldman Sachs analysts Jerren Holder and Michael Lapides have a positive view of the Midstream energy stocks moving toward positive free cash flows, with Conviction Buy-rated Kinder Morgan (KMI) as their top pick. In a broader research note, the analysts also upgraded Plains All American (PAA) and Cheniere Energy (LNG) to Buy from Neutral and Semgroup (SEMG) and Sunoco (SUN) to Neutral from Sell. The analysts note that the "simplification thesis" in the sector continues to play out, volumes are growing, and "many new takeaway pipelines are coming online", even though the midstream stocks' performance has been lagging. Holder and Lapides believe that an inflection is ahead with more major projects coming online after a period of high capital spending.
01/02/19
GSCO
01/02/19
UPGRADE
Target $82
GSCO
Buy
Cheniere Energy upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Michael Lapides upgraded Cheniere Energy to Buy from Neutral and raised his price target to $82 from $81.
OPRX OptimizeRx
$12.51

0.5 (4.16%)

01/03/19
WBLR
01/03/19
INITIATION
WBLR
Outperform
OptimizeRx well positioned for 'industry mega trends,' says William Blair
William Blair analyst Ryan Daniels initiated coverage of OptimizeRx with an Outperform rating. The analyst laid out six primary reasons for why he views OptimizeRx shares as an attractive small-cap healthcare technology holding. OptimizeRx's solutions address a critical, but largely unmet need for both pharmaceutical companies and physicians, Daniels tells investors in a research note. Further, he believes it is well positioned to benefit from "several industry mega trends" that will drive organic growth.
01/03/19
WBLR
01/03/19
INITIATION
WBLR
Outperform
OptimizeRx initiated with an Outperform at William Blair
William Blair analyst Ryan Daniels started OptimizeRx with an Outperform rating.
11/06/18
LSCM
11/06/18
NO CHANGE
Target $20
LSCM
Buy
OptimizeRx price target raised to $20 from $18 at Lake Street
Lake Street analyst Eric Martinuzzi raised his price target for OptimizeRx to $20 saying the company reported "another solid quarter." He notes that CareSpeak is expected to add an additional $1M to revenue and be accretive to adjusted earnings in 2019. The analyst keeps a Buy rating on OptimizeRx.
11/06/18
ROTH
11/06/18
NO CHANGE
Target $30
ROTH
Buy
OptimizeRx price target raised to $30 from $25 at Roth Capital
Roth Capital analyst Richard Baldry lowered his price target for OptimizeRx to $30 from $25 on "impressive" Q3 results, with 75% organic growth supporting record revenues, a second quarter of GAAP profitability, growing pro forma EPS and 28% adjusted operating margins. The analyst reiterates a Buy rating on the shares.
CMA Comerica
$69.65

-0.08 (-0.11%)

12/12/18
KBWI
12/12/18
DOWNGRADE
Target $87
KBWI
Market Perform
Comerica downgraded to Market Perform from Outperform at Keefe Bruyette
Keefe Bruyette analyst Brian Klock downgraded Comerica to Market Perform and lowered his price target for the shares to $87 from $110.
12/10/18
RILY
12/10/18
DOWNGRADE
Target $84
RILY
Neutral
Comerica downgraded to Neutral from Buy at B. Riley FBR
B. Riley FBR analyst Steve Moss downgraded Comerica to Neutral and lowered his price target for the shares to $84 from $107. The analyst says the downgrade reflects a more difficult interest rate environment.
01/03/19
ARGS
01/03/19
INITIATION
Target $88
ARGS
Buy
Comerica initiated with a Buy at Argus
Argus analyst Kevin Heal initiated Comerica with a Buy rating and a price target of $88, saying the company has continued to increase revenue and EPS. The analyst also notes that Comerica's valuation of 8.7-times forward earnings multiple is a discount to regional bank peers in spite of its above-peer-average growth prospects. Heal is positive on the contribution from Comerica's "increased middle-market lending, improved cost controls, and wider net interest margins", with added benefits coming from its "strong capital levels and a high loan-to-deposit ratio."
12/12/18
KBWI
12/12/18
DOWNGRADE
KBWI
Market Perform
Keefe, wanting to own defensive banks, downgrades Comerica and KeyCorp
Keefe Bruyette analyst Brian Klock expects the narrative in 2019 to shift to "defensive banks that can grow earnings using other levers rather than depending on rates." With that in mind, the analyst downgraded both Comerica (CMA) and KeyCorp (KEY) to Market Perform from Outperform. Comerica's revenue and earnings growth are largely dependent upon future Fed funds hikes, Klock tells investors in a research note. Further, he sees risk to his revenue growth assumptions next year for KeyCorp and does not see 2019 as the year the company's price-to-earnings multiple closes the discount compared to peers. Klock's top overweight picks among the Large Regionals are Citizens Financial (CFG), M&T Bank (MTB), SunTrust (STI) and Zions Bancorp (ZION).
KL Kirkland Lake Gold
$26.48

0.4 (1.53%)

07/18/18
BMOC
07/18/18
DOWNGRADE
BMOC
Market Perform
Kirkland Lake Gold downgraded to Market Perform from Outperform at BMO Capital
01/03/19
ROTH
01/03/19
INITIATION
Target $31
ROTH
Buy
Kirkland Lake Gold initiated with a Buy at Roth Capital
Roth Capital analyst Jake Sekelsky started Kirkland Lake Gold with a Buy rating and a $31 price target. The analyst believes the company is well positioned to deliver "strong" cash flow while executing on its stated objective to grow production to approximately 1.0M ounces by 2021.

TODAY'S FREE FLY STORIES

WFC

Wells Fargo

$53.80

0.3 (0.56%)

, AAPL

Apple

$265.73

3.07 (1.17%)

10:01
11/16/19
11/16
10:01
11/16/19
10:01
Periodicals
Berkshire Hathaway inactive with record cash hoard, Barron's says »

Berkshire Hathaway…

WFC

Wells Fargo

$53.80

0.3 (0.56%)

AAPL

Apple

$265.73

3.07 (1.17%)

OXY

Occidental Petroleum

$38.94

1.18 (3.13%)

BRK.B

Berkshire Hathaway

$219.74

0.38 (0.17%)

BRK.A

Berkshire Hathaway

$329,361.11

266.11 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

DIS

Disney

$144.63

-2.56 (-1.74%)

09:43
11/16/19
11/16
09:43
11/16/19
09:43
Periodicals
Disney+ may not be able to hold onto huge number of subs, Barron's says »

While Disney's (DIS)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$112.11

2.9 (2.66%)

09:27
11/16/19
11/16
09:27
11/16/19
09:27
Periodicals
Medtronic shares 'could rise even more,' Barron's says »

Barron's recommended…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

BR

Broadridge

$119.80

0.485 (0.41%)

09:18
11/16/19
11/16
09:18
11/16/19
09:18
Periodicals
Broadridge a defensive name that can withstand slowdown, Barron's says »

Broadridge Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCD

McDonald's

$193.95

-0.02 (-0.01%)

, MDT

Medtronic

$112.11

2.9 (2.66%)

09:07
11/16/19
11/16
09:07
11/16/19
09:07
Periodicals
Barron's suggests dividend stocks for retirement savers »

In this week's…

MCD

McDonald's

$193.95

-0.02 (-0.01%)

MDT

Medtronic

$112.11

2.9 (2.66%)

KO

Coca-Cola

$52.67

0.03 (0.06%)

PRU

Prudential

$93.61

0.82 (0.88%)

SYF

Synchrony

$37.05

0.34 (0.93%)

KEY

KeyCorp

$18.96

0.1 (0.53%)

T

AT&T

$39.49

0.53 (1.36%)

AMGN

Amgen

$220.84

2.29 (1.05%)

CSCO

Cisco

$45.10

0.18 (0.40%)

RCL

Royal Caribbean

$117.91

2.69 (2.33%)

MRK

Merck

$84.89

0.33 (0.39%)

JNJ

Johnson & Johnson

$134.97

3.99 (3.05%)

MSFT

Microsoft

$149.95

1.89 (1.28%)

JPM

JPMorgan

$129.51

0.83 (0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 22

    Nov

  • 02

    Dec

  • 04

    Dec

  • 07

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 10

    Dec

  • 14

    Jan

  • 21

    Jan

  • 23

    Jan

  • 24

    Jan

  • 24

    Jan

  • 29

    Jan

  • 05

    Feb

  • 12

    Feb

  • 14

    Mar

AMZN

Amazon.com

$1,737.49

-17.22 (-0.98%)

, MSFT

Microsoft

$149.95

1.89 (1.28%)

08:54
11/16/19
11/16
08:54
11/16/19
08:54
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AMZN

Amazon.com

$1,737.49

-17.22 (-0.98%)

MSFT

Microsoft

$149.95

1.89 (1.28%)

AAPL

Apple

$265.73

3.07 (1.17%)

CI

Cigna

$196.08

6.41 (3.38%)

CNC

Centene

$57.57

2.91 (5.32%)

CVS

CVS Health

$74.27

1.34 (1.84%)

HUM

Humana

$335.43

17.48 (5.50%)

UNH

UnitedHealth

$269.44

13.68 (5.35%)

WCG

WellCare

$312.01

10.155 (3.36%)

HNT

Health Net

$0.00

(0.00%)

MOH

Molina Healthcare

$129.60

7.3 (5.97%)

ANTM

Anthem

$298.18

16.14 (5.72%)

HCA

HCA Healthcare

$137.98

3.51 (2.61%)

CYH

Community Health

$3.12

0.25 (8.71%)

LPNT

LifePoint

$0.00

(0.00%)

UHS

Universal Health

$144.30

3.13 (2.22%)

THC

Tenet

$30.55

1.08 (3.66%)

GM

General Motors

$36.87

0.07 (0.19%)

FCAU

Fiat Chrysler

$16.02

0.04 (0.25%)

TM

Toyota

$144.29

1.16 (0.81%)

F

Ford

$8.96

0.16 (1.82%)

HMC

Honda

$28.99

0.155 (0.54%)

VWAGY

Volkswagen

$0.00

(0.00%)

BMWYY

BMW

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

  • 22

    Nov

  • 04

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 13

    Dec

  • 04

    Feb

  • 06

    Feb

MDCO

The Medicines Co.

$51.92

1.03 (2.02%)

04:55
11/16/19
11/16
04:55
11/16/19
04:55
Conference/Events
Roth Capital pharmaceuticals analysts to hold a luncheon »

Analysts host Dr. John…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

CVET

Covetrus

$14.93

1.44 (10.67%)

18:41
11/15/19
11/15
18:41
11/15/19
18:41
Hot Stocks
Covetrus CEO: We're a leader in the humanization of pets »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSK

Comcast

$0.00

(0.00%)

, CMCSA

Comcast

$44.54

-0.93 (-2.05%)

18:02
11/15/19
11/15
18:02
11/15/19
18:02
Hot Stocks
Viacom extends cable deal for 'The Office' through 2025 »

Viacom (VIA) announced…

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$44.54

-0.93 (-2.05%)

VIAB

Viacom

$23.07

0.59 (2.62%)

VIA

Viacom

$26.59

1.28 (5.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

CWK

Cushman & Wakefield

$19.10

0.1 (0.53%)

17:48
11/15/19
11/15
17:48
11/15/19
17:48
Hot Stocks
Cushman & Wakefield CEO sells 84.6K share of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

LMT

Lockheed Martin

$393.52

3.305 (0.85%)

17:39
11/15/19
11/15
17:39
11/15/19
17:39
Hot Stocks
Lockheed Martin awarded maximum $3.33B Air Force contract »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESCA

Escalade

$10.90

-0.09 (-0.82%)

17:38
11/15/19
11/15
17:38
11/15/19
17:38
Hot Stocks
Escalade CEO Fetherman to retire »

Escalade announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZR

Caesars

$12.96

0.1 (0.78%)

, ERI

Eldorado Resorts

$52.10

0.93 (1.82%)

17:38
11/15/19
11/15
17:38
11/15/19
17:38
Hot Stocks
Eldorado, Caesars stockholders approve Eldorado acquisition of Caesars »

Eldorado Resorts (ERI)…

CZR

Caesars

$12.96

0.1 (0.78%)

ERI

Eldorado Resorts

$52.10

0.93 (1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

EGRX

Eagle Pharmaceuticals

$57.24

0.55 (0.97%)

17:15
11/15/19
11/15
17:15
11/15/19
17:15
Syndicate
Breaking Syndicate news story on Eagle Pharmaceuticals »

Eagle Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FN

Fabrinet

$60.82

0.84 (1.40%)

17:11
11/15/19
11/15
17:11
11/15/19
17:11
Hot Stocks
Fabrinet President Gill sells 12.9K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

TEUM

Pareteum

$0.38

-0.0209 (-5.21%)

17:05
11/15/19
11/15
17:05
11/15/19
17:05
Hot Stocks
Pareteum receives noncompliance notice from Nasdaq »

Pareteum announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEXO

Hexo

$1.78

-0.1 (-5.32%)

17:00
11/15/19
11/15
17:00
11/15/19
17:00
Hot Stocks
Hexo was cannabis was being grown in unlicensed space at Niagara site »

HEXO Corp provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$220.84

2.29 (1.05%)

, CELG

Celgene

$110.02

-0.01 (-0.01%)

16:57
11/15/19
11/15
16:57
11/15/19
16:57
Hot Stocks
Bristol-Myers gets FTC clearance for Celgene acquisition »

Bristol-Myers Squibb…

AMGN

Amgen

$220.84

2.29 (1.05%)

CELG

Celgene

$110.02

-0.01 (-0.01%)

BMY

Bristol-Myers

$58.61

0.11 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 04

    Dec

  • 07

    Dec

  • 25

    Mar

  • 04

    Apr

RAVE

Rave Restaurant

$1.44

-0.79 (-35.43%)

16:47
11/15/19
11/15
16:47
11/15/19
16:47
Hot Stocks
BBRC Asset Management reports 6.6% passive stake in Rave Restaurant »

BBRC Asset Management …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHAP

Chaparral Energy

$0.89

-0.0521 (-5.52%)

16:46
11/15/19
11/15
16:46
11/15/19
16:46
Hot Stocks
Chaparral Energy receives continued listing standard notice from NYSE »

Chaparral Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:45
11/15/19
11/15
16:45
11/15/19
16:45
General news
Breaking General news story  »

San Francisco Federal…

16:45
11/15/19
11/15
16:45
11/15/19
16:45
General news
Breaking General news story  »

San Francisco Federal…

CI

Cigna

$196.08

6.41 (3.38%)

, CNC

Centene

$57.57

2.91 (5.32%)

16:41
11/15/19
11/15
16:41
11/15/19
16:41
On The Fly
Fly Intel: Wall Street's top stories for Friday »

Stocks closed out the…

CI

Cigna

$196.08

6.41 (3.38%)

CNC

Centene

$57.57

2.91 (5.32%)

CVS

CVS Health

$74.27

1.34 (1.84%)

HUM

Humana

$335.43

17.48 (5.50%)

UNH

UnitedHealth

$269.44

13.68 (5.35%)

WCG

WellCare

$312.01

10.155 (3.36%)

HNT

Health Net

$0.00

(0.00%)

MOH

Molina Healthcare

$129.60

7.3 (5.97%)

ANTM

Anthem

$298.18

16.14 (5.72%)

HCA

HCA Healthcare

$137.98

3.51 (2.61%)

CYH

Community Health

$3.12

0.25 (8.71%)

LPNT

LifePoint

$0.00

(0.00%)

UHS

Universal Health

$144.30

3.13 (2.22%)

NVDA

Nvidia

$204.12

-5.76 (-2.74%)

AMZN

Amazon.com

$1,739.33

-15.38 (-0.88%)

MSFT

Microsoft

$149.95

1.89 (1.28%)

UAA

Under Armour

$17.78

0.65 (3.79%)

UA

Under Armour

$15.97

0.41 (2.64%)

AMRN

Amarin

$23.99

2.5 (11.63%)

JNJ

Johnson & Johnson

$134.97

3.99 (3.05%)

GOOG

Alphabet

$1,334.01

21.82 (1.66%)

GOOGL

Alphabet Class A

$1,333.33

23.54 (1.80%)

ORCL

Oracle

$56.43

0.33 (0.59%)

RH

RH

$188.73

13.535 (7.73%)

QGEN

Qiagen

$40.56

3.255 (8.73%)

FTCH

Farfetch

$9.66

2.17 (28.97%)

THC

Tenet

$30.55

1.08 (3.66%)

TORC

resTORbio

$1.10

-6.83 (-86.13%)

ACB

Aurora Cannabis

$2.72

-0.57 (-17.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 22

    Nov

  • 04

    Dec

  • 07

    Dec

  • 09

    Dec

  • 09

    Dec

  • 13

    Dec

  • 28

    Dec

  • 06

    Jan

  • 21

    Jan

  • 06

    Feb

NYT

New York Times

$31.60

0.44 (1.41%)

16:41
11/15/19
11/15
16:41
11/15/19
16:41
Hot Stocks
New York Times CEO sells 66,000 class A common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

WEX

Wex

$200.52

4.61 (2.35%)

16:41
11/15/19
11/15
16:41
11/15/19
16:41
Hot Stocks
Wex director Morris sells 3K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.